TAG:
lab test
Quality Strategy Earns Honor for SD Laboratory
By Robert Michel | From the Volume XVII No. 14 – October 4, 2010 Issue
CEO SUMMARY: Here’s a new lab product launch with a surprise twist. Upon earning FDA clearance for its new HIV Ag/Ab Combo Assay this spring, Abbott Diagnostics selected a hospital laboratory in Sioux Falls, South Dakota, to be the nation’s first clinical lab to offer the ass…
Labs Can Turn the Tables on the Payers
By R. Lewis Dark | From the Volume XVII No. 13 – September 13, 2010 Issue
PRE-AUTHORIZATION OF GENETIC AND MOLECULAR TESTS is now on the radar screen of the nation’s larger health insurance companies. In most circumstances, payer pre-authorization requirements serve to exclude many smaller providers from access to patients. But local labs have a chance to guarantee their…
Two New Lab Companies Will Open in L.A. & Denver
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: It is unprecedented for two multi-billion-dollar health systems to announce laboratory testing outreach joint ventures just days apart. In Los Angeles, Providence Health & Services will partner with PAML to start a commercial lab company in the San Fernando Valle…
More Hospitals Consider PAML’s Lab JV Model
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: One joint venture at a time, PAML is convincing hospital and health system CEOs about the benefits of building a thriving laboratory outreach business. For their part, facing budget cutbacks and a decline in Medicare reimbursement, more hospital administrato…
Payers Move to Pre-Authorize Expensive Genetic Tests
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO Summary: Pre-authorization of expensive genetic and molecular tests is fast-becoming a priority for most of the nation’s health insurers. For clinical labs and pathology groups that don’t respond, this trend is a threat. On the other hand, because payers need all the skil…
Tough Financial Times Ahead for Hospital Labs
By R. Lewis Dark | From the Volume XVII No. 12 – August 23, 2010 Issue
THIS YEAR’S MASSIVE HEALTH REFORM LEGISLATION has a ticking financial time bomb for hospital laboratories. Starting October 1, Medicare Part A hospital fees will be reduced by 0.4% for the federal fiscal year 2011. This is expected to reduce Medicare Part A spending by $440 million in 2011 compared…
Labs Hope to Renegotiate 1.75% Medicare Fee Cuts
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: As Congress crafted its reform of the nation’s healthcare system last year, it asked healthcare providers to contribute substantially to the cost of the Patient Protection and Affordable Care Act. The lab industry will see a 1.75% cut in reimbursement for Medicare …
More Hospitals Now Use Point-of-Care Test Devices
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: Point-of-care testing (POCT) continues to gain acceptance in hospitals across the nation. One factor in this trend is improved technology for both the POC assays and the POC systems, each of which contributes to a more accurate and reproducible POC test result. But a…
HIEs Boost Fortunes of Community Hospital Labs
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: Regional health information exchanges (HIEs) are becoming more common. In Southern Indiana, the HealthLINC HIE is boosting the value that the community hospital laboratory provides to physicians. At the top of the list is expedited turnaround of laboratory test resul…
Steps Toward the Globalization of Lab Medicine
By R. Lewis Dark | From the Volume XVII No. 11 – August 2, 2010 Issue
PATHOLOGISTS AND LABORATORY EXECUTIVES in this country generally don’t pay much attention to what is happening to clinical laboratories and anatomic pathology services in other countries. That is understandable, since there is lots of change unfolding in the lab testing marketplace within this coun…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized